GO
Loading...

Drugs

More

  • Luis Videgaray, finance minister of Mexico, says the U.S. must "share responsibility" for tackling drug cartels.

  • WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

  • Maine Medicaid rules reduce narcotic prescriptions Thursday, 10 Apr 2014 | 12:01 PM ET

    PORTLAND, Maine— Maine's severe restrictions on opioid painkillers for Medicaid patients, requiring many to instead seek alternative pain management treatment for the past year, have sharply reduced the number of people obtaining highly addictive medications blamed for drug abuse and deaths around the nation.

  • Pfizer CEO worries about ACA coverage     Thursday, 10 Apr 2014 | 11:43 AM ET

    Ian Read, Pfizer CEO, discusses the pricing and affordability of drugs in the U.S. Read also weighs in on insurance coverage under the Affordable Care Act.

  • Zohydro maker sues to block Massachusetts ban Monday, 7 Apr 2014 | 5:15 PM ET

    Zogenix filed suit in U.S. District Court in Massachusetts on Monday requesting that the court temporarily stop Massachusetts Governor Deval Patrick's executive order. The San Diego- based company argues in its lawsuit that Governor Patrick's order is at odds with the U.S. Food and Drug Administration, which approved use of Zohydro for severe pain in October.

  • Diversifying your pharma portfolio     Monday, 7 Apr 2014 | 1:07 PM ET

    Mallinckrodt is buying drug maker Questcor for $5.6 billion. Barbara Ryan, FTI Consulting managing director, discusses consolidation in pharmaceuticals and shares what stocks she likes in the space.

  • States rebel against powerful new painkiller Friday, 4 Apr 2014 | 9:58 AM ET

    The Food and Drug Administration approved the drug last fall and it hit the market last month. Harry Chen both questioned the FDA approval. "So you know, we're just saying' Hey, we understand we don't control the FDA, but we do have some influence in Vermont,'" he said.

  • FDA approves easy-to-use heroin overdose antidote Thursday, 3 Apr 2014 | 11:07 AM ET

    The Food and Drug Administration on Thursday approved an easy-to-use device that automatically injects the right dose of an overdose antidote named naloxone before an ambulance arrives. The FDA said Evzio's design makes it easy for anyone to administer.

  • Why this $84,000 drug costs just $900 abroad Saturday, 29 Mar 2014 | 2:29 PM ET

    Why do some drugs, like Gilead's Sovaldi, cost more in the U.S. than in other countries. Shelia Dharmarajian reports for "Nightly Business Report."

  • CALGARY, Alberta, March 27- Canada's largest oil producer, Suncor Energy Inc, said on Thursday it will appeal a legal decision preventing the company from carrying out random drug and alcohol tests on workers at its northern Alberta oil sands sites.

  • 'Eye-opening' new report about statin eligibility Wednesday, 19 Mar 2014 | 5:06 PM ET
    Lipitor tablets

    Almost half of Americans ages 40 to 75 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines.

  • Zogenix shares fall after Purdue advances rival drug Wednesday, 12 Mar 2014 | 9:37 AM ET

    March 12- Shares of Zogenix Inc fell 14 percent after Purdue Pharma LP said it was moving ahead with an abuse-resistant rival to Zogenix's much-criticised painkiller.

  • The Zohydro debate: More harm than good?     Tuesday, 11 Mar 2014 | 3:20 PM ET

    Powerful new pain killer Zohydro, is prescribed to help people with chronic pain. Dr. Andrew Kolodny thinks the FDA has put out a drug that will kill people. Dr. Steven Garner, New York Methodist Hospital, thinks the drug will help many people who are suffering with lasting pain.

  • Controversial drug Zohydro here to stay?     Tuesday, 11 Mar 2014 | 1:00 PM ET

    CNBC's Sheila Dharmarajan discusses the new pain killer Zohydro which contains the same addictive elements as Oxycodone.

  • The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.

  • Groups urge FDA to halt launch of Zohydro pain drug Thursday, 27 Feb 2014 | 12:42 PM ET

    The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.

  • The go-to guy: A conversation with a drug dealer Wednesday, 26 Feb 2014 | 3:25 PM ET

    While out exploring marijuana's first legal frontier, CNBC took a moment to catch up with one young man who has stayed on the darker side of weed—the illegal side.

  • Dabs—marijuana's explosive secret Wednesday, 26 Feb 2014 | 12:37 PM ET
    Nicholas Broms, who was involved in a drug-related explosion last November. Broms was one of the growing number of casualties from manufacturing hash oil, a potent marijuana byproduct made with butane.

    From exploding kitchens to super-intense highs, making and smoking marijuana concentrate—aka “dabs”—is getting more attention in the move toward legalization.

  • Open Vape: The e-cigarette of legal pot Wednesday, 26 Feb 2014 | 12:12 PM ET

    Todd Mitchem's company, Open Vape, manufactures a product similar to an e-cigarette. It's a pen that heats a cartridge filled with purified cannabis oil.

  • Jane West: Wife, mother and 'potrepreneur' Tuesday, 25 Feb 2014 | 5:49 PM ET

    West, who lives in an affluent Denver suburb, calls herself "one part Martha Stewart and one part Walter White."

Most Popular Video

Wednesday, 16 Apr 2014 | 9:37 AM ET

CNBC's Bob Pisani looks at what's likely to move in early morning trading, including the public debut of Moelis & Company, and a look at bank earnings and market leaders.

Wednesday, 16 Apr 2014 | 7:50 AM ET

John Calipari, University of Kentucky basketball coach, discusses building "servant leadership" in his team, and the big business of college basketball.

Wednesday, 16 Apr 2014 | 9:04 AM ET

The "Squawk on the Street" news team break down Bank of America's Q1 earnings loss thanks largely to legal expenses related to the financial crisis.